The diabetes epidemic continues to grow at a staggering rate, despite the billions of dollars invested in drug development. Ironically, the "silver bullet" won't be the next new pill. Rather, it's moving patients off their medications by addressing the root cause of type 2 diabetes. This concept is baked into the core of Virta's care model.
In 2019 Virta rolled out its diabetes reversal treatment to 12+ employers. On this webinar, we'll showcase this cohort's results for the first time.
Sign up to hear from consultant Kara Speer, alongside employers who participated in the pilot, clinical leadership from Virta, and actual patients who benefited from the treatment. We will discuss:
Key webinar topics will include:
The Diabetes Vendor Landscape
Frameworks for Building a Pilot Cohort
Clinical Outcomes from the Pilot
Voices from Employers and Patients
Register for the webinar
This webinar will feature the following panelists:
Kara Speer, MPH
Director of Health Management, Willis Towers Watson
Former US Benefits Manager at Sealed Air, Benefits Director at Honeywell